<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01039467</url>
  </required_header>
  <id_info>
    <org_study_id>COMPARE Study</org_study_id>
    <nct_id>NCT01039467</nct_id>
  </id_info>
  <brief_title>A Comparison of the Pacemaker Automatic Features in Reduction of Ventricular Pacing</brief_title>
  <acronym>COMPARE</acronym>
  <official_title>Study of a Comparison of the Pacemaker Automatic Features in Reduction of Ventricular Pacing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Cardiac Rhythm and Heart Failure</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Cardiac Rhythm and Heart Failure</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The COMPARE-Adapta study is a randomized, multi-center, prospective study conducted in China.
      The purpose of the study is to compare the ability of Search AV™+ and Managed Ventricular
      Pacing® (MVP®) to reduce ventricular pacing in dual chamber pacemaker-indicated patients. The
      COMPARE-Adapta study will also observe atrial fibrillation (AF) burden as demonstrated by
      Cardiac Compass® and the clinical profile Adapta® pacemaker patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recent studies suggest that chronic right ventricular pacing is associated with a variety of
      adverse effects in patients, particularly those with intact or intermittent atrioventricular
      (AV) conduction.

      Medtronic Adapta® pacemakers include Managed Ventricular Pacing®, a pacing mode designed to
      promote intrinsic conduction, and also Search AV™+, a feature designed to reduce unnecessary
      ventricular pacing in patients with intact or intermittent AV conduction.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Decreased Percent of Ventricular Pacing Compared to MVP Using Search AV+</measure>
    <time_frame>1 month post-implantation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent of Ventricular Pacing</measure>
    <time_frame>12 months post-implantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Reduced Percent of Atrial Fibrillation (AF) Burden 1-month Post-Implant</measure>
    <time_frame>1 month post-implantation</time_frame>
    <description>To compare the ability of Search AV™+ and Managed Ventricular Pacing® (MVP®) to reduce ventricular pacing in dual chamber pacemaker-indicated patients by measuring the percent burden of atrial fibrillation (AF) burden as demonstrated by Cardiac Compass® and the clinical profile Adapta® pacemaker patients.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Percent of Ventricular Pacing</measure>
    <time_frame>from 1 month to 12 months post-implantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Percent Ventricular Pacing Reduced to Lower Levels (&lt;10%VP)</measure>
    <time_frame>1 month post-implantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Decreased Percent Ventricular Pacing Stratified by Baseline Atrioventricular Block Status (No AVB - nAVB)</measure>
    <time_frame>1 month post-implantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent of Ventricular Pacing Stratified by Baseline AV Block Status (1st Degree - 1AVB)</measure>
    <time_frame>1 month post-implantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent of Ventricular Pacing Stratified by Baseline AV Block Status (2nd Degree Type I &amp; II - 2AVB)</measure>
    <time_frame>1 month post-implantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent of Ventricular Pacing Stratified by Baseline AV Block Status (3rd Degree Episodic - e3AVB)</measure>
    <time_frame>1 month post-implantation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">385</enrollment>
  <condition>Bradycardia</condition>
  <arm_group>
    <arm_group_label>Managed Ventricular Pacing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Managed Ventricular Pacing group: programmed on</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Search AV+</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Search AV+: programmed on</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Medtronic Adapta Dual Chamber Pacemaker</intervention_name>
    <description>Medtronic Adapta Dual Chamber Pacemaker</description>
    <arm_group_label>Managed Ventricular Pacing</arm_group_label>
    <arm_group_label>Search AV+</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed and dated study informed consent

          -  Class I or Class IIa pacemaker indication

          -  Geographically stable and available for follow-up at the center for the length of the
             study

          -  Age greater than 18

          -  To be implanted with Adapta dual chamber pacemaker

        Exclusion Criteria:

          -  Unwillingness or inability to give written informed consent to participate in the
             Study

          -  Patient with a previously implanted pacemaker/Implantable Cardioverter-Defibrillator
             (ICD)/Cardiac Resynchronization Therapy (CRT) device

          -  Life expectancy of less than one year

          -  Patient has a mechanical tricuspid heart valve

          -  Medical conditions that preclude the testing requirement by the protocol or limit
             study participation

          -  Patient has persistent 3rd degree atrioventricular (AV) block

          -  Patient has persistent atrial fibrillation (AF)

          -  Patient has neurogenic syncope

          -  Patient has carotid sinus syndrome

          -  Patient has hypertrophic obstructive cardiomyopathy

          -  Inclusion in another clinical trial or study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shu Zhang, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fuwai Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>3rd Hospital of Beijing University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Anzhen Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beijing Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fuwai Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fujian Province Hospital</name>
      <address>
        <city>Fuzhou</city>
        <state>Fujian</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1st Hospital of Zhongshan Medical University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>2nd Hospital of Zhongshan Medical University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guangdong Province People's Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1st Hospital of Zhengzhou University</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wuhan Asian Heart Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wuhan Union Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Xiangya Second Hospital, Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nanjing Drum Tower Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>2nd Hospital of Jilin University</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Liaoning Province People's Hospital</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Affiliated Hospital of Qingdao Medical College</name>
      <address>
        <city>Qingdao</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shanghai Huadong Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shanghai Minhang District Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General Hospital of Tianjin Medical University</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tianjin Chest Hospital</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>First Affiliated Hospital of Xinjiang Medical University</name>
      <address>
        <city>Urumqi</city>
        <state>Xinjiang</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Xinjiang Automatic District Hospital</name>
      <address>
        <city>Ürümqi</city>
        <state>Xinjiang</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1st Hospital of Kunming Medical College</name>
      <address>
        <city>Kunming</city>
        <state>Yunnan</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yunnan Province 1st People's Hospital</name>
      <address>
        <city>Kunming</city>
        <state>Yunnan</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yuxi People's Hospital</name>
      <address>
        <city>Yuxi</city>
        <state>Yunnan</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1st Hospital of Medical College, Zhejiang University</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>2nd Hospital of Medical College, Zhejiang University</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hangzhou First People's Hospital</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zhejiang Hospital</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shanghai First People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>December 23, 2009</study_first_submitted>
  <study_first_submitted_qc>December 23, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 25, 2009</study_first_posted>
  <results_first_submitted>October 10, 2016</results_first_submitted>
  <results_first_submitted_qc>January 23, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">February 5, 2020</results_first_posted>
  <last_update_submitted>January 23, 2020</last_update_submitted>
  <last_update_submitted_qc>January 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Managed Ventricular Pacing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bradycardia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Enrollment period: 18 JUN 2009 to 15 MAR 2010.</recruitment_details>
      <pre_assignment_details>6 patients withdrawn from study pre-randomization for not meeting inclusion/exclusion criteria.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Managed Ventricular Pacing (MVP)</title>
          <description>Managed Ventricular Pacing (MVP) used in dual chamber pacemaker</description>
        </group>
        <group group_id="P2">
          <title>Search AV+</title>
          <description>Search AV+ used in dual chamber pacemaker</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="196"/>
                <participants group_id="P2" count="189"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="156"/>
                <participants group_id="P2" count="140"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="49"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Managed Ventricular Pacing (MVP)</title>
          <description>Managed Ventricular Pacing (MVP) used in dual chamber pacemaker</description>
        </group>
        <group group_id="B2">
          <title>Search AV+</title>
          <description>Search AV+ used in dual chamber pacemaker</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="196"/>
            <count group_id="B2" value="189"/>
            <count group_id="B3" value="385"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69.87" spread="10.35"/>
                    <measurement group_id="B2" value="70.71" spread="9.89"/>
                    <measurement group_id="B3" value="70.28" spread="10.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="93"/>
                    <measurement group_id="B2" value="81"/>
                    <measurement group_id="B3" value="174"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="103"/>
                    <measurement group_id="B2" value="108"/>
                    <measurement group_id="B3" value="211"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>China</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="196"/>
                    <measurement group_id="B2" value="189"/>
                    <measurement group_id="B3" value="385"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Decreased Percent of Ventricular Pacing Compared to MVP Using Search AV+</title>
        <time_frame>1 month post-implantation</time_frame>
        <population>all participants who completed the 1 month visit with %VP data available.</population>
        <group_list>
          <group group_id="O1">
            <title>Managed Ventricular Pacing</title>
            <description>Managed Ventricular Pacing (MVP)</description>
          </group>
          <group group_id="O2">
            <title>Search AV+</title>
            <description>Search AV+ (SAV+)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Decreased Percent of Ventricular Pacing Compared to MVP Using Search AV+</title>
          <population>all participants who completed the 1 month visit with %VP data available.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="167"/>
                <count group_id="O2" value="163"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other (legacy)</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent of Ventricular Pacing</title>
        <time_frame>12 months post-implantation</time_frame>
        <population>all participants who completed the 12 months visit with %VP data available.</population>
        <group_list>
          <group group_id="O1">
            <title>Managed Ventricular Pacing</title>
            <description>Managed Ventricular Pacing (MVP)</description>
          </group>
          <group group_id="O2">
            <title>Search AV+</title>
            <description>Search AV+ (SAV+)</description>
          </group>
        </group_list>
        <measure>
          <title>Percent of Ventricular Pacing</title>
          <population>all participants who completed the 12 months visit with %VP data available.</population>
          <units>percent of ventricular pacing (%VP)</units>
          <param>Median</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="156"/>
                <count group_id="O2" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.40" spread="31.46"/>
                    <measurement group_id="O2" value="2.95" spread="40.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other (legacy)</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Reduced Percent of Atrial Fibrillation (AF) Burden 1-month Post-Implant</title>
        <description>To compare the ability of Search AV™+ and Managed Ventricular Pacing® (MVP®) to reduce ventricular pacing in dual chamber pacemaker-indicated patients by measuring the percent burden of atrial fibrillation (AF) burden as demonstrated by Cardiac Compass® and the clinical profile Adapta® pacemaker patients.</description>
        <time_frame>1 month post-implantation</time_frame>
        <population>all participants who completed the 1 month visit with
%AT/AF burden data available.</population>
        <group_list>
          <group group_id="O1">
            <title>Managed Ventricular Pacing</title>
            <description>Managed Ventricular Pacing (MVP)</description>
          </group>
          <group group_id="O2">
            <title>Search AV+</title>
            <description>Search AV+ (SAV+)</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Reduced Percent of Atrial Fibrillation (AF) Burden 1-month Post-Implant</title>
          <description>To compare the ability of Search AV™+ and Managed Ventricular Pacing® (MVP®) to reduce ventricular pacing in dual chamber pacemaker-indicated patients by measuring the percent burden of atrial fibrillation (AF) burden as demonstrated by Cardiac Compass® and the clinical profile Adapta® pacemaker patients.</description>
          <population>all participants who completed the 1 month visit with
%AT/AF burden data available.</population>
          <units>Percentage of decreasedAT/AF burden</units>
          <param>Median</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.40" spread="20.27"/>
                    <measurement group_id="O2" value="0.50" spread="25.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other (legacy)</non_inferiority_type>
            <p_value>0.833</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Percent of Ventricular Pacing</title>
        <time_frame>from 1 month to 12 months post-implantation</time_frame>
        <population>all participants who completed the 12 months visit with %VP data available.</population>
        <group_list>
          <group group_id="O1">
            <title>Managed Ventricular Pacing</title>
            <description>Managed Ventricular Pacing (MVP)</description>
          </group>
          <group group_id="O2">
            <title>Search AV+</title>
            <description>Search AV+ (SAV+)</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Percent of Ventricular Pacing</title>
          <population>all participants who completed the 12 months visit with %VP data available.</population>
          <units>percent of ventricular pacing (%VP)</units>
          <param>Median</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="141"/>
                <count group_id="O2" value="129"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.10" spread="20.20"/>
                    <measurement group_id="O2" value="0.00" spread="20.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other (legacy)</non_inferiority_type>
            <p_value>0.265</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Percent Ventricular Pacing Reduced to Lower Levels (&lt;10%VP)</title>
        <time_frame>1 month post-implantation</time_frame>
        <population>all participants who completed the 12 months visit with %VP data available.</population>
        <group_list>
          <group group_id="O1">
            <title>Managed Ventricular Pacing</title>
            <description>Managed Ventricular Pacing (MVP)</description>
          </group>
          <group group_id="O2">
            <title>Search AV+</title>
            <description>Search AV+ (SAV+)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Percent Ventricular Pacing Reduced to Lower Levels (&lt;10%VP)</title>
          <population>all participants who completed the 12 months visit with %VP data available.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="167"/>
                <count group_id="O2" value="163"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="132"/>
                    <measurement group_id="O2" value="91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other (legacy)</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Decreased Percent Ventricular Pacing Stratified by Baseline Atrioventricular Block Status (No AVB - nAVB)</title>
        <time_frame>1 month post-implantation</time_frame>
        <population>all participants who completed the 1 month visit with %VP data available.</population>
        <group_list>
          <group group_id="O1">
            <title>No AV Block</title>
            <description>Patients with no atrioventricular block</description>
          </group>
          <group group_id="O2">
            <title>nAVB</title>
            <description>Patients with atrioventricular block</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Decreased Percent Ventricular Pacing Stratified by Baseline Atrioventricular Block Status (No AVB - nAVB)</title>
          <population>all participants who completed the 1 month visit with %VP data available.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="105"/>
                <count group_id="O2" value="110"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other (legacy)</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent of Ventricular Pacing Stratified by Baseline AV Block Status (1st Degree - 1AVB)</title>
        <time_frame>1 month post-implantation</time_frame>
        <population>all participants who completed the 1 month visit with %VP data available.</population>
        <group_list>
          <group group_id="O1">
            <title>Managed Ventricular Pacing</title>
            <description>Managed Ventricular Pacing (MVP)</description>
          </group>
          <group group_id="O2">
            <title>Search AV+</title>
            <description>Search AV+ (SAV+)</description>
          </group>
        </group_list>
        <measure>
          <title>Percent of Ventricular Pacing Stratified by Baseline AV Block Status (1st Degree - 1AVB)</title>
          <population>all participants who completed the 1 month visit with %VP data available.</population>
          <units>percent of ventricular pacing (%VP)</units>
          <param>Median</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.50" spread="23.65"/>
                    <measurement group_id="O2" value="21.80" spread="41.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other (legacy)</non_inferiority_type>
            <p_value>0.0008</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent of Ventricular Pacing Stratified by Baseline AV Block Status (2nd Degree Type I &amp; II - 2AVB)</title>
        <time_frame>1 month post-implantation</time_frame>
        <population>all participants who completed the 1 month visit with %VP data available.</population>
        <group_list>
          <group group_id="O1">
            <title>Managed Ventricular Pacing</title>
            <description>Managed Ventricular Pacing (MVP)</description>
          </group>
          <group group_id="O2">
            <title>Search AV+</title>
            <description>Search AV+ (SAV+)</description>
          </group>
        </group_list>
        <measure>
          <title>Percent of Ventricular Pacing Stratified by Baseline AV Block Status (2nd Degree Type I &amp; II - 2AVB)</title>
          <population>all participants who completed the 1 month visit with %VP data available.</population>
          <units>percent of ventricular pacing (%VP)</units>
          <param>Median</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.40" spread="39.16"/>
                    <measurement group_id="O2" value="80.60" spread="44.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other (legacy)</non_inferiority_type>
            <p_value>0.053</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent of Ventricular Pacing Stratified by Baseline AV Block Status (3rd Degree Episodic - e3AVB)</title>
        <time_frame>1 month post-implantation</time_frame>
        <population>all participants who completed the 1 month visit with %VP data available.</population>
        <group_list>
          <group group_id="O1">
            <title>Managed Ventricular Pacing</title>
            <description>Managed Ventricular Pacing (MVP)</description>
          </group>
          <group group_id="O2">
            <title>Search AV+</title>
            <description>Search AV+ (SAV+)</description>
          </group>
        </group_list>
        <measure>
          <title>Percent of Ventricular Pacing Stratified by Baseline AV Block Status (3rd Degree Episodic - e3AVB)</title>
          <population>all participants who completed the 1 month visit with %VP data available.</population>
          <units>percent of ventricular pacing (%VP)</units>
          <param>Median</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.20" spread="44.68"/>
                    <measurement group_id="O2" value="22.45" spread="47.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other (legacy)</non_inferiority_type>
            <p_value>0.493</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>12 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Managed Ventricular Pacing</title>
          <description>Managed Ventricular Pacing (MVP)</description>
        </group>
        <group group_id="E2">
          <title>Search AV+</title>
          <description>Search AV+ (SAV+)</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="196"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="189"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Death (unknown reason)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="196"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="189"/>
              </event>
              <event>
                <sub_title>Sudden cardiac death (CHD)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="196"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="189"/>
              </event>
              <event>
                <sub_title>Non-cardiac death (cancer)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="196"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="189"/>
              </event>
              <event>
                <sub_title>Non-cardiac death (cerebrovascular accident）</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="196"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="189"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Pocket infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="196"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="189"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Dislodgement of RV lead and reposition of the lead</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="196"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="189"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="196"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="189"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>dizziness</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="196"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="189"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Shu Zhang</name_or_title>
      <organization>Fuwai Hospital</organization>
      <phone>861088398833</phone>
      <email>zsfuwai@vip.163.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

